US Patent Issued to ORANO MED on Aug. 4 for "PSMA-targeting conjugate and uses thereof" (American, French Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,697,404, issued on Aug. 4, was assigned to ORANO MED (Chatillon, France).

"PSMA-targeting conjugate and uses thereof" was invented by Amal Saidi (Thonon-Les-Bains, France), Amy Wong (Richardson, Texas), Julien Torgue (Gaithersburg, Md.) and Tania Stallons (Wylie, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "A PSMA-targeting conjugate or a pharmaceutically acceptable salt which may be used either for preparing a radiopharmaceutical or, once labeled with a radionuclide, as a radiopharmaceutical. The conjugate is of formula (I): A1-L1-Ch-L2-A2 (I)wherein: Ch is a chelator, L1 and L2, identical or different, are a linker whereas A1 and A2, identical ...